Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Obol (OBOL) Price & Performance

InjectiveTrade
ObolTrade

Price performance (Past 24H)

Key statistics

Injective vs Obol — how do they compare? Injective trades at Rp92,050 (market cap Rp9,23T, Rp1,78T 24h volume), while Obol trades at Rp157.55 (market cap Rp30,1M, Rp51,72M 24h volume). The key difference: Injective is far larger — about 306644.5× Obol's market cap, and Obol's supply is capped (161,3M / 500M OBOL (33%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Obol for 14 Days on average.

INJOBOL
Market Cap
Rp9,23TRp30,1M
Volume (24h)
Rp1,78TRp51,72M
Circulating Supply
100M INJ161,3M / 500M OBOL (33%)
Typical Hold Time
36 Days14 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Obol

Obol currently has a market cap of Rp30.1M with a circulating supply of 161.3 million tokens out of a maximum 500 million, indicating 33% circulation. The token exhibits a 14-day average hold time, suggesting moderate short-term holding behavior. No recent price or volume data is available, limiting technical trend analysis. There are no major protocol updates or ecosystem developments reported recently, with network activity appearing subdued.

Outlook remains cautious due to limited data and low market cap, presenting speculative opportunities if ecosystem activity increases. Key risks include extreme volatility, low liquidity, and regulatory uncertainty inherent to small-cap cryptocurrencies. Investors should monitor for new exchange listings or protocol upgrades that could drive adoption.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
OBOL

No sentiment data available yet.

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Obol

Obol develops vital technologies that enhance Ethereum's decentralization and security, currently protecting billions in staked ETH. Its Distributed Validators (DVs) offer better uptime, lower risk, and improved performance compared to traditional staking. Using the middleware Charon, DVs enable Ethereum validators to function across multiple operators and machines, featuring threshold signing and distributed key generation for added resilience. The Obol Collective, powered by the OBOL Token, includes the largest decentralized operator ecosystem with major players like Lido and Blockdaemon. The Obol Stack simplifies the deployment of Ethereum nodes and other decentralized infrastructures, advancing the Ethereum economy.

Read more on OBOL